Global Heart Valve Devices Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2023 –2030 |
 حجم السوق (السنة الأساسية) |
|
 حجم السوق (سنة التنبؤ) |
USD 23,665.51 |
 CAGR |
% |
| Major Markets Players |
>السوق العالمية لأجهزة صمامات القلب، حسب نوع المنتج (صمامات القلب الميكانيكية، وصمامات القلب البيولوجية، وصمامات القسطرة)، والعلاج (الجراحة المفتوحة والجراحة الأقل توغلاً (MIS))، والمستخدم النهائي (المستشفيات والعيادات، ومراكز الجراحة الخارجية ، ومراكز القلب، ومراكز الأبحاث وغيرها)، وقناة التوزيع (العطاء المباشر، والموزعون الخارجيون)، واتجاهات الصناعة والتوقعات حتى عام 2030.
تحليل ورؤى حول سوق أجهزة صمام القلب
تُستخدم أجهزة صمامات القلب لعلاج صمامات القلب المسدودة، وزرع هذه الأجهزة هو أحد الإجراءات الأكثر شيوعًا. تشمل أجهزة صمامات القلب البنيوية المتوفرة في السوق الصمامات الميكانيكية والبيولوجية والقسطرة. من المرجح أن ينمو سوق أجهزة صمامات القلب العالمية بشكل مطرد خلال فترة التنبؤ بسبب العدد المتزايد من جراحات صمامات القلب في جميع أنحاء العالم. من المتوقع أن يكون نمو سوق أجهزة صمامات القلب العالمية مدفوعًا بالتطورات في أجهزة القلب البنيوية والإجراءات مثل صمامات الأبهر وأجهزة انسداد الأذين الأيسر وصمامات الأنسجة أو البيولوجية. لقد أحدثت صمامات الأنسجة ثورة في سوق أجهزة صمام القلب. تقدم جراحات صمامات القلب من الجيل التالي ملفات تعريف منخفضة للمرضى، وجراحات أكثر تحكمًا، ووظيفة صمام أفضل، وارتجاع صمامي أقل، ومتانة متزايدة، وتكاليف أقل. عززت ابتكارات المنتجات من قبل اللاعبين الرئيسيين في السوق نمو السوق من خلال تمكينهم من معالجة عدد أكبر من المرضى وتحقيق نتائج سريرية أفضل.
تحلل شركة Data Bridge Market Research أن سوق أجهزة صمامات القلب من المتوقع أن تصل قيمته إلى 23,665.51 مليون دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب قدره 13.4% خلال الفترة المتوقعة. يشكل نوع المنتج أكبر شريحة من الأنواع في السوق بسبب الطلب السريع على أجهزة صمامات القلب على مستوى العالم. يغطي تقرير السوق هذا أيضًا تحليل الأسعار وتحليل براءات الاختراع والتقدم التكنولوجي بعمق.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2023 إلى 2030 |
|
سنة الأساس |
2022 |
|
سنوات تاريخية |
2021 (قابلة للتخصيص حتى 2020 - 2015) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية، الأحجام بالوحدات، التسعير بالدولار الأمريكي |
|
القطاعات المغطاة |
حسب نوع المنتج (صمامات القلب الميكانيكية وصمامات القلب البيولوجية وصمامات القسطرة)، العلاج (الجراحة المفتوحة والجراحة قليلة التوغل (MIS))، المستخدم النهائي (المستشفيات والعيادات ومراكز الجراحة الخارجية ومراكز القلب ومراكز الأبحاث وغيرها)، قناة التوزيع (العطاء المباشر، الموزعون التابعون لجهات خارجية). |
|
الدول المغطاة |
الولايات المتحدة، كندا، المكسيك، ألمانيا، فرنسا، المملكة المتحدة، إيطاليا، روسيا، إسبانيا، هولندا، سويسرا، النرويج، بولندا، السويد، بلجيكا، تركيا، الدنمارك، فنلندا وبقية أوروبا، الصين، اليابان، الهند، أستراليا، نيوزيلندا، كوريا الجنوبية، سنغافورة، ماليزيا، تايلاند، إندونيسيا، الفلبين، فيتنام، تايوان وبقية دول آسيا والمحيط الهادئ، جنوب أفريقيا، المملكة العربية السعودية، البحرين، الإمارات العربية المتحدة، الكويت، عمان، قطر، إسرائيل، مصر وبقية دول الشرق الأوسط وأفريقيا، البرازيل، الأرجنتين وبقية دول أمريكا الجنوبية. |
|
الجهات الفاعلة في السوق المشمولة |
Abbott، Boston Scientific Corporation أو الشركات التابعة لها، Artivion, Inc.، Edwards Lifesciences Corporation، Medtronic، NeoVasc، Micro Interventional Devices Incorporated، XELTIS، TTK، Meril Life Sciences Pvt. Ltd، Foldax, Inc.، Venus Medtech (Hangzhou) Inc.، Colibri Heart Valve وغيرها. |
تعريف السوق العالمية لأجهزة صمامات القلب
صمامات القلب ضرورية لتسهيل حركة الدم في الاتجاه الصحيح في الجسم. صمامات القلب مسؤولة عن تدفق الدم المستمر والحفاظ على ضغط الدم. إذا لم تعمل بشكل صحيح فإن قطع القلب يسبب تضيقًا. تشمل أمراض القلب عمومًا العديد من الأمراض التي تؤثر بشكل كبير على القلب. زاد تنظيم صمامات القلب بسرعة في السنوات العشر الماضية مع زيادة عدد المرضى الذين يعانون من أمراض القلب والأوعية الدموية. يتسارع نمو سوق صمامات القلب بسبب عوامل مثل أنماط الحياة غير المستقرة وأمراض نمط الحياة وزيادة عدد المدخنين والشيخوخة السكانية وزيادة جودة الرعاية الصحية والتطور السريع لسداد الرعاية الصحية خلال فترة التنبؤ. بالإضافة إلى ذلك، قد تكون التكلفة العالية لصمامات القلب وخطر إصابة غرسات القلب السبب الذي من المرجح أن يبطئ نمو سوق صمام القلب خلال فترة التنبؤ المذكورة أعلاه. إن النمو في جوانب الأعمال الطبية والعمل الأساسي في الاقتصادات الناشئة يغذي النمو في السياحة الطبية، مما يدفع سوق أجهزة صمام القلب. لقد زادت الحاجة إلى الإجراءات الأقل توغلاً لعلاج التشوهات القلبية بشكل كبير. لقد أفسحت التطبيقات الحالية للأتمتة في جراحة صمامات القلب، مثل استبدال الصمام الأورطي عن طريق القسطرة (TAVR)، المجال لمجموعة متنوعة ومتزايدة من الجراحات المماثلة. وبالنظر إلى النسبة المتزايدة من السكان المسنين، فمن المتوقع أيضًا أن تساهم الزيادة في وثائق التأمين على الحياة في نمو سوق صمامات القلب.
ديناميكيات سوق أجهزة صمامات القلب العالمية
يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. وسيتم مناقشة كل هذا بالتفصيل أدناه:
السائقين
- الابتكارات في أجهزة صمامات القلب تقدم نتائج سريرية أفضل
من المرجح أن يؤدي إطلاق منتجات جديدة للإجراءات الأقل توغلاً إلى دفع سوق أجهزة صمام القلب العالمية. لقد أحدثت صمامات الأنسجة ثورة في سوق صمام القلب. يوفر الجيل التالي من جراحة صمام القلب منحنيات توصيل أقل، ووضعًا أكثر تحكمًا، ووظيفة صمام محسنة، وتقليل ارتجاع الصمام، وزيادة المتانة، وخفض التكلفة. عزز ابتكار المنتجات آفاق نمو اللاعبين في سوق أجهزة صمام القلب حيث يمكنها علاج عدد أكبر من المرضى بنتائج سريرية متفوقة. على الرغم من التقدم الكبير في السنوات الأخيرة، لا تزال أمراض القلب التداخلية البنيوية سوقًا ناشئة ذات إمكانات كبيرة.
علاوة على ذلك، تواصل التصميمات الذكية والتقنيات الجديدة وتطبيقات المواد الحيوية دفع حدود تطوير المنتجات الجديدة، مما يضمن أن تكون هذه الأجهزة في طليعة ابتكار المنتجات التدخلية لسنوات قادمة. تساعد ابتكارات التصميم اللاعبين في السوق على الاستفادة من فرص النمو المربحة في أجهزة صمام القلب.
ومن المتوقع أن يتعزز نمو سوق أجهزة صمامات القلب العالمية بفضل الارتفاع في الابتكارات في أجهزة صمامات القلب.
- ارتفاع عدد أمراض القلب المختلفة
عادة ما تكون النوبات القلبية والسكتات الدماغية أحداثًا حادة وتحدث في المقام الأول بسبب انسداد يمنع تدفق الدم إلى القلب أو الدماغ. خلال العام الأول من جائحة كوفيد-19، زادت الوفيات الناجمة عن أمراض القلب والسكتات الدماغية بنسبة 5.8% و6.8% على التوالي. ومع ذلك، كانت الزيادات المرتبطة بالعمر 1.6% و1.7% لأمراض القلب والسكتة الدماغية على التوالي. والسبب الأكثر شيوعًا هو تراكم الرواسب الدهنية في بطانة الأوعية الدموية التي تغذي القلب أو الدماغ. يمكن أن تحدث السكتة الدماغية بسبب النزيف أو جلطات الدم في أحد الأوعية الدموية في الدماغ. يشير هذا الاتجاه إلى أن معدل الإصابة بأمراض القلب والأوعية الدموية قد يزيد بشكل كبير بسبب النمو السكاني والشيخوخة.
علاوة على ذلك، فإن ارتفاع نسبة السكر في الدم وارتفاع نسبة الكوليسترول في الدم والتدخين هي عوامل خطر رئيسية لأمراض القلب. يعاني حوالي نصف الأشخاص في الولايات المتحدة (47%) من أحد عوامل الخطر الثلاثة هذه على الأقل. يمكن أن تؤدي الحالات الطبية الأخرى واختيارات نمط الحياة أيضًا إلى زيادة خطر الإصابة بأمراض القلب لدى الأشخاص، بما في ذلك النظام الغذائي غير الصحي، وقلة النشاط البدني، والإفراط في تعاطي الكحول.
علاوة على ذلك، من المتوقع أن يعمل العدد المتزايد من أمراض القلب كمحرك لسوق أجهزة صمام القلب العالمية.
فرصة
- زيادة الوعي بالأجهزة الاصطناعية
الصمام الاصطناعي هو جهاز مصمم لاستبدال جزء مفقود من الجسم أو لتحسين وظيفة جزء من الجسم. تُستخدم صمامات القلب الاصطناعية بشكل متزايد في حالات تشوهات الصمامات الطبيعية التي تتطلب التدخل. بشكل عام، يمكن تقسيمها إلى صمامات قلب ميكانيكية وصمامات بيولوجية وطعوم متماثلة. الهدف من الصمامات الاصطناعية هو العمل ديناميكيًا مثل الصمام الطبيعي مع الحد الأدنى من الآثار الجانبية. تم تطوير أجهزة الأطراف الاصطناعية القلبية الوعائية لاستبدال أنسجة القلب التالفة. تم تصميم هذه الأجهزة الطبية لمحاكاة وظيفة الأعضاء القلبية الوعائية الطبيعية. تسمح القلوب الاصطناعية لجراحي القلب بزيادة علاج انسداد القلب.
علاوة على ذلك، يتراوح معدل انتشار الصمامات الاصطناعية من 0.2 لكل 1000 شخص في الأشخاص الذين تبلغ أعمارهم 10 سنوات أو أقل إلى 5.3 في الأشخاص الذين تبلغ أعمارهم 10 سنوات أو أقل.
ومن ثم فإن الوعي المتزايد بشأن الأجهزة الاصطناعية يعد بمثابة فرصة لنمو السوق.
ضبط النفس/التحدي
- تكلفة إنتاج المعدات باهظة الثمن
إن عدد المرضى الذين يتم علاجهم من مرض الصمام الأورطي في الولايات المتحدة ينمو بسرعة. ويحل استبدال الصمام الأورطي عن طريق القسطرة محل استبدال الصمام الأورطي الجراحي والعلاج الطبي. والعواقب الاقتصادية لهذه الاتجاهات غير معروفة. وبالتالي، فإن التكلفة الإجمالية لاستبدال الصمام الأورطي عن طريق القسطرة أعلى من استبدال الصمام الأورطي الجراحي وأكثر تكلفة بكثير من استبدال الصمام الأورطي وحده. وقد انخفضت تكاليف استبدال الصمام الأورطي عن طريق القسطرة بمرور الوقت، بينما ظلت تكاليف استبدال الصمام الأورطي الجراحي والعلاج الطبي كما هي.
بالإضافة إلى ذلك، فإن التكلفة الجراحية المرتفعة لـ TAVI ترجع بشكل أساسي إلى التكلفة العالية للإنتاج. ومع ذلك، نظرًا لقصر مدة الإقامة في المستشفى، فإن تكلفة TAVI غير الجراحية أقل مقارنة بـ AVR. تبلغ تكلفة مجموعة زرع TAVI وحدها (الصمام، البالون، الغلاف) 32500 دولار، بينما يكلف الصمام الجراحي حوالي 5000 دولار فقط، تمامًا كما هو الحال في سويسرا، حيث تكلف مجموعة زرع TAVI حوالي 32000 فرنك سويسري (حوالي 35000 دولار)، بينما تبلغ تكلفة الطرف الاصطناعي الجراحي حوالي 3000 فرنك سويسري (حوالي 3300 دولار أمريكي). وبحسب الأمراض المصاحبة والمضاعفات، يتراوح التعويض في الولايات المتحدة بين 0000 و5000 دولار، وتبلغ عملية TAVI في سويسرا حوالي 72000 فرنك سويسري (78000 دولار)، وتبلغ عملية AVR حوالي 3000 فرنك سويسري (7000 دولار)، وهو ما يعني خسارة مالية للمستشفى.
ومن ثم، فإن ارتفاع تكاليف إنتاج المعدات قد يعوق نمو السوق.
التطورات الأخيرة
- في سبتمبر 2023، أصدرت شركة أبوت بيانات من خمسة عروض تقديمية في مرحلة متأخرة تُظهر فوائد أجهزتها قليلة التدخل في علاج الأشخاص المصابين بأمراض القلب البنيوية المختلفة. تتضمن البيانات نتائج تدعم قيمة MitraClip™. إنه أول وأهم إصلاح عبر القسطرة من الحافة إلى الحافة (TEER) في العالم لعلاج الصمامات المتسربة لدى الأشخاص المصابين بقصور الصمام التاجي (MR). تم تقديم بيانات جديدة حول علاجات القلب البنيوية لشركة أبوت في الندوة العلمية السنوية الرابعة والثلاثين لعلاج القلب والأوعية الدموية عبر القسطرة (TCT) لمؤسسة أبحاث القلب والأوعية الدموية في بوسطن. وقد ساعد هذا الشركة على زيادة مكانتها التجارية في السوق.
- في سبتمبر 2020، أعلنت شركة Boston Scientific Corporation أنها أطلقت نظام صمام الأبهر ACURATE neo2™ في أوروبا. تعد تقنية زرع صمام الأبهر عبر القسطرة (TAVI) من الجيل التالي منصة جديدة مصممة بميزات متعددة لتحسين الأداء السريري لمنصة ACURATE الجديدة الأصلية. مقارنةً بالجيل السابق، يتمتع نظام صمام ACURATE neo2 بمؤشر موسع للمرضى الذين يعانون من تضيق الأبهر. وقد ساعد هذا الشركة على اكتساب مجموعة منتجاتها.
نطاق سوق أجهزة صمام القلب العالمية
يتم تقسيم سوق أجهزة صمامات القلب إلى نوع المنتج والعلاج والمستخدم النهائي وقناة التوزيع. يساعدك النمو بين القطاعات على تحليل جيوب النمو والاستراتيجيات المتخصصة للتعامل مع السوق وتحديد مجالات التطبيق الأساسية والاختلاف في الأسواق المستهدفة.
حسب نوع المنتج
- صمامات القلب الميكانيكية
- صمامات القلب البيولوجية
- صمامات القسطرة
على أساس نوع المنتج، يتم تقسيم سوق أجهزة صمام القلب إلى صمامات القلب الميكانيكية وصمامات القلب البيولوجية وصمامات القسطرة.
عن طريق العلاج
- الجراحة المفتوحة
- الجراحة الأقل تدخلاً
على أساس العلاج، يتم تقسيم سوق أجهزة صمام القلب إلى جراحة مفتوحة وجراحة طفيفة التوغل.
بواسطة المستخدم النهائي
- المستشفى والعيادات
- مراكز الجراحة الخارجية
- مراكز القلب
- مراكز البحوث
- آحرون
على أساس المستخدم النهائي، يتم تقسيم سوق أجهزة صمام القلب إلى المستشفيات والعيادات ومراكز الجراحة الخارجية ومراكز القلب ومراكز الأبحاث وغيرها.
حسب قناة التوزيع
- العطاء المباشر
- موزعين الطرف الثالث
على أساس قناة التوزيع، يتم تقسيم سوق أجهزة صمام القلب إلى موزعين مباشرين وموزعين تابعين لجهات خارجية.
تحليل/رؤى إقليمية لسوق أجهزة صمامات القلب العالمية
يتم تحليل سوق أجهزة صمام القلب وتوفير معلومات حجم السوق ونوع المنتج والعلاج والمستخدم النهائي وقناة التوزيع.
الدول التي يغطيها تقرير السوق هذا هي الولايات المتحدة وكندا والمكسيك وألمانيا وفرنسا والمملكة المتحدة وإيطاليا وروسيا وإسبانيا وهولندا وسويسرا والنرويج وبولندا والسويد وبلجيكا وتركيا والدنمارك وفنلندا وبقية أوروبا والصين واليابان والهند وأستراليا ونيوزيلندا وكوريا الجنوبية وسنغافورة وماليزيا وتايلاند وإندونيسيا والفلبين وفيتنام وتايوان وبقية دول آسيا والمحيط الهادئ وجنوب إفريقيا والمملكة العربية السعودية والبحرين والإمارات العربية المتحدة والكويت وعمان وقطر وإسرائيل ومصر وبقية دول الشرق الأوسط وأفريقيا والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية.
تهيمن أمريكا الشمالية على السوق بسبب الاستثمار المتزايد في البحث والتطوير. تهيمن الولايات المتحدة على منطقة أمريكا الشمالية بسبب الوجود القوي للاعبين الرئيسيين. تهيمن ألمانيا على منطقة أوروبا بسبب الإنتاج الضخم لأجهزة صمام القلب والطلب المتزايد من الأسواق الناشئة وتوسع صناعات الرعاية الصحية. تهيمن الصين على منطقة آسيا والمحيط الهادئ بسبب ارتفاع توافر أجهزة الجراحة المتعلقة بأمراض صمام القلب.
كما يوفر قسم الدولة في التقرير عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير قنوات المبيعات أثناء تقديم تحليل توقعات لبيانات الدولة.
تحليل المنافسة وحصة السوق العالمية لأجهزة صمامات القلب
يوفر المشهد التنافسي لسوق أجهزة صمام القلب تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وخطوط أنابيب تجارب المنتجات، وموافقات المنتج، وبراءات الاختراع، وعرض المنتج والتنفس، وهيمنة التطبيق، ومنحنى شريان الحياة التكنولوجي. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة على سوق أجهزة صمام القلب.
بعض اللاعبين الرئيسيين العاملين في سوق أجهزة صمام القلب هم Abbott و Boston Scientific Corporation أو الشركات التابعة لها و Artivion، Inc. و Edwards Lifesciences Corporation و Medtronic و NeoVasc و Micro Interventional Devices Incorporated و XELTIS و TTK و Meril Life Sciences Pvt. Ltd و Foldax، Inc. و Venus Medtech (Hangzhou) Inc. و Colibri Heart Valve وغيرها.
منهجية البحث: السوق العالمية لأجهزة صمام القلب
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. بالإضافة إلى ذلك، يعد تحليل حصة السوق وتحليل الاتجاهات الرئيسية من عوامل النجاح الرئيسية في تقرير السوق. منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي مثلث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأساسي (خبير الصناعة). وبصرف النظر عن هذا، تتضمن نماذج البيانات شبكة وضع البائعين، وتحليل الخط الزمني للسوق، ونظرة عامة على السوق والدليل، وشبكة وضع الشركة، وتحليل حصة الشركة في السوق، ومعايير القياس، والتحليل العالمي مقابل الإقليمي، وتحليل حصة البائعين. يرجى طلب مكالمة محلل في حالة وجود استفسار آخر.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. نحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. يمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان) وبيانات نتائج التجارب السريرية ومراجعة الأدبيات وتحليل السوق المجدد وقاعدة المنتج. يمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. يمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. يمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (Factbook) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL HEART VALVE DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 EPIDEMIOLOGY
3.2 PESTEL ANALYSIS
3.3 PORTER'S FIVE FORCE
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME
4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES
4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY
4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES
4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT
4.3 OPPORTUNITIES
4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES
4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES
4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES
4.4 CHALLENGES
4.4.1 STRICT GOVERNMENT REGULATIONS
4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT
5 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVES
5.2.1 AORTIC VALVE
5.2.2 MITRAL VALVE
5.3 BIOLOGICAL HEART VALVES
5.3.1 AORTIC VALVE
5.3.2 MITRAL VALVE
5.3.3 PULMONARY VALVE
5.3.4 TRICUSPID VALVE
5.4 TRANSCATHETER VALVE
5.4.1 AORTIC VALVE
5.4.2 MITRAL VALVE
5.4.3 PULMONARY VALVE
6 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE SURGERY (MIS)
6.2.1 CARDIAC VALVE REPLACEMENT
6.2.2 CARDIAC VALVE REPAIR
6.3 OPEN SURGERY
6.3.1 CARDIAC VALVE REPLACEMENT
6.3.2 CARDIAC VALVE REPAIR
7 GLOBAL HEART VALVE DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL & CLINICS
7.3 AMBULATORY SURGICAL CENTERS
7.4 CARDIAC CENTERS
7.5 RESEARCH CENTERS
7.6 OTHERS
8 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 THIRD PARTY DISTRIBUTORS
9 GLOBAL HEART VALVE DEVICES MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 SOUTH AMERICA
9.3.1 BRAZIL
9.3.2 ARGENTINA
9.3.3 REST OF SOUTH AMERICA
9.4 EUROPE
9.4.1 GERMANY
9.4.2 FRANCE
9.4.3 U.K.
9.4.4 ITALY
9.4.5 RUSSIA
9.4.6 SPAIN
9.4.7 TURKEY
9.4.8 NETHERLANDS
9.4.9 SWITZERLAND
9.4.10 BELGIUM
9.4.11 DENMARK
9.4.12 SWEDEN
9.4.13 POLAND
9.4.14 NORWAY
9.4.15 FINLAND
9.4.16 REST OF EUROPE
9.5 ASIA-PACIFIC
9.5.1 CHINA
9.5.2 JAPAN
9.5.3 SOUTH KOREA
9.5.4 INDIA
9.5.5 AUSTRALIA
9.5.6 SINGAPORE
9.5.7 TAIWAN
9.5.8 THAILAND
9.5.9 MALAYSIA
9.5.10 INDONESIA
9.5.11 PHILIPPINES
9.5.12 NEW ZEALAND
9.5.13 VIETNAM
9.5.14 REST OF ASIA-PACIFIC
9.6 MIDDLE EAST AND AFRICA
9.6.1 SOUTH AFRICA
9.6.2 SAUDI ARABIA
9.6.3 U.A.E.
9.6.4 EGYPT
9.6.5 ISRAEL
9.6.6 KUWAIT
9.6.7 QATAR
9.6.8 OMAN
9.6.9 BAHRAIN
9.6.10 REST OF MIDDLE EAST AND AFRICA
10 GLOBAL HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 EDWARDS LIFESCIENCES CORPORATION
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ARTIVION, INC.
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 COLIBRI HEART VALVE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 FOLDAX, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 MERIL LIFE SCIENCES PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 NEOVASC
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 TTK
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 VENUS MEDTECH (HANGZHOU) INC.
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 XELTIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 33 U.S. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 35 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 36 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 37 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 38 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 39 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 40 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 42 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 43 U.S. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 44 U.S. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 45 U.S. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 46 U.S. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 U.S. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 CANADA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 51 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 52 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 54 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 55 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 57 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 58 CANADA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 59 CANADA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 60 CANADA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 61 CANADA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 CANADA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 MEXICO HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 66 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 67 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 69 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 70 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 72 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 73 MEXICO HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 74 MEXICO MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 75 MEXICO OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 76 MEXICO HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 MEXICO HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 78 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 79 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 SOUTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 SOUTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 SOUTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 84 SOUTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 85 SOUTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 86 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 88 BRAZIL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 91 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 92 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 94 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 95 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 97 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 98 BRAZIL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 99 BRAZIL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 100 BRAZIL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 101 BRAZIL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 102 BRAZIL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 103 ARGENTINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 106 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 107 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 109 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 110 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 111 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 112 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 113 ARGENTINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 114 ARGENTINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 115 ARGENTINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 116 ARGENTINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 ARGENTINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 118 REST OF SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 EUROPE HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 120 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 125 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 126 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 127 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 128 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 129 GERMANY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 132 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 133 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 134 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 135 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 136 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 138 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 139 GERMANY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 140 GERMANY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 141 GERMANY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 142 GERMANY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 143 GERMANY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 144 FRANCE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 147 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 148 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 150 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 151 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 153 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 154 FRANCE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 155 FRANCE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 156 FRANCE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 157 FRANCE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 FRANCE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 159 U.K. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 162 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 163 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 165 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 166 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 168 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 169 U.K. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 170 U.K. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 171 U.K. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 172 U.K. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 173 U.K. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 174 ITALY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 177 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 178 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 180 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 181 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 183 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 184 ITALY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 185 ITALY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 186 ITALY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 187 ITALY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 ITALY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 189 RUSSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 192 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 193 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 195 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 196 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 198 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 199 RUSSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 200 RUSSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 203 RUSSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 204 SPAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 207 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 208 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 209 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 210 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 211 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 213 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 214 SPAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 215 SPAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 216 SPAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 217 SPAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 218 SPAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 219 TURKEY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 222 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 223 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 225 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 226 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 227 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 228 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 229 TURKEY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 230 TURKEY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 231 TURKEY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 232 TURKEY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 233 TURKEY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 234 NETHERLANDS HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 237 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 238 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 240 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 241 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 243 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 244 NETHERLANDS HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 245 NETHERLANDS MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 246 NETHERLANDS OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 247 NETHERLANDS HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 248 NETHERLANDS HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 249 SWITZERLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 250 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 251 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 252 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 253 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 254 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 255 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 256 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 258 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 259 SWITZERLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 260 SWITZERLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 261 SWITZERLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 262 SWITZERLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 SWITZERLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 264 BELGIUM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 267 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 268 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 270 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 271 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 273 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 274 BELGIUM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 275 BELGIUM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 276 BELGIUM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 277 BELGIUM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 BELGIUM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 DENMARK HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 282 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 283 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 285 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 286 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 287 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 288 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 289 DENMARK HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 290 DENMARK MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 291 DENMARK OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 292 DENMARK HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 293 DENMARK HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 294 SWEDEN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 297 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 298 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 299 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 300 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 301 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 302 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 303 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 304 SWEDEN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 305 SWEDEN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 306 SWEDEN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 307 SWEDEN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 SWEDEN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 POLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 311 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 312 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 313 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 315 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 316 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 318 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 319 POLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 320 POLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 321 POLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 322 POLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 323 POLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 324 NORWAY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 326 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 327 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 328 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 330 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 331 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 333 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 334 NORWAY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 335 NORWAY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 336 NORWAY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 337 NORWAY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 338 NORWAY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 339 FINLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 342 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 343 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 345 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 346 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 347 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 348 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 349 FINLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 350 FINLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 351 FINLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 352 FINLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 353 FINLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 354 REST OF EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 355 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 356 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 ASIA-PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 358 ASIA-PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 ASIA-PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 360 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 361 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 362 ASIA-PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 363 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 365 CHINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 366 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 367 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 368 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 369 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 370 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 371 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 372 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 373 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 374 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 375 CHINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 376 CHINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 377 CHINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 378 CHINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 379 CHINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 380 JAPAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 381 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 382 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 383 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 384 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 386 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 387 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 389 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 390 JAPAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 391 JAPAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 392 JAPAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 393 JAPAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 394 JAPAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 395 SOUTH KOREA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 398 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 399 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 401 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 402 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 404 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 405 SOUTH KOREA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 406 SOUTH KOREA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 407 SOUTH KOREA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 408 SOUTH KOREA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 409 SOUTH KOREA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 410 INDIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 411 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 412 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 413 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 414 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 415 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 416 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 417 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 418 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 419 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 420 INDIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 421 INDIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 422 INDIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 423 INDIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 424 INDIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 425 AUSTRALIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 426 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 427 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 428 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 429 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 430 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 431 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 432 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 433 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 434 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 435 AUSTRALIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 436 AUSTRALIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 437 AUSTRALIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 438 AUSTRALIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 439 AUSTRALIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 440 SINGAPORE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 443 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 444 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 445 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 446 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 447 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 449 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 450 SINGAPORE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 451 SINGAPORE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 452 SINGAPORE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 453 SINGAPORE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 454 SINGAPORE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 455 TAIWAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 458 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 459 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 461 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 462 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 464 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 465 TAIWAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 466 TAIWAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 467 TAIWAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 468 TAIWAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 469 TAIWAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 470 THAILAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 471 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 472 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 473 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 474 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 475 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 476 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 477 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 478 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 479 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 480 THAILAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 481 THAILAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 482 THAILAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 483 THAILAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 484 THAILAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 485 MALAYSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 486 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 487 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 488 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 489 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 490 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 491 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 492 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 493 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 494 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 495 MALAYSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 496 MALAYSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 497 MALAYSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 498 MALAYSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 499 MALAYSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 500 INDONESIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 501 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 502 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 503 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 504 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 505 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 506 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 507 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 508 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 509 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 510 INDONESIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 511 INDONESIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 512 INDONESIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 513 INDONESIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 514 INDONESIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 515 PHILIPPINES HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 516 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 517 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 518 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 519 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 520 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 521 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 522 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 523 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 524 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 525 PHILIPPINES HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 526 PHILIPPINES MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 527 PHILIPPINES OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 528 PHILIPPINES HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 529 PHILIPPINES HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 530 NEW ZEALAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 531 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 532 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 533 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 534 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 535 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 536 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 537 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 538 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 539 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 540 NEW ZEALAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 541 NEW ZEALAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 542 NEW ZEALAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 543 NEW ZEALAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 544 NEW ZEALAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 545 VIETNAM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 546 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 547 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 548 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 549 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 550 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 551 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 552 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 553 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 554 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 555 VIETNAM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 556 VIETNAM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 557 VIETNAM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 558 VIETNAM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 559 VIETNAM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 560 REST OF ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 561 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 562 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 563 MIDDLE EAST AND AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 564 MIDDLE EAST AND AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 565 MIDDLE EAST AND AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 566 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 567 MIDDLE EAST AND AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 568 MIDDLE EAST AND AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 569 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 570 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 571 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 572 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 573 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 574 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 575 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 576 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 577 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 578 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 579 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 580 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 581 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 582 SOUTH AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 583 SOUTH AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 584 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 585 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 586 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 587 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 588 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 589 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 590 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 591 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 592 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 593 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 594 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 595 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 596 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 597 SAUDI ARABIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 598 SAUDI ARABIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 599 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 600 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 601 U.A.E. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 602 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 603 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 604 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 605 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 606 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 607 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 608 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 609 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 610 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 611 U.A.E. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 612 U.A.E. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 613 U.A.E. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 614 U.A.E. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 615 U.A.E. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 616 EGYPT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 617 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 618 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 619 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 620 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 621 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 622 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 623 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 624 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 625 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 626 EGYPT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 627 EGYPT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 628 EGYPT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 629 EGYPT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 630 EGYPT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 631 ISRAEL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 632 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 633 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 634 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 635 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 636 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 637 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 638 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 639 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 640 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 641 ISRAEL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 642 ISRAEL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 643 ISRAEL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 644 ISRAEL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 645 ISRAEL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 646 KUWAIT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 647 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 648 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 649 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 650 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 651 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 652 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 653 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 654 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 655 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 656 KUWAIT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 657 KUWAIT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 658 KUWAIT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 659 KUWAIT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 660 KUWAIT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 661 QATAR HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 662 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 663 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 664 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 665 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 666 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 667 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 668 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 669 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 670 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 671 QATAR HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 672 QATAR MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 673 QATAR OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 674 QATAR HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 675 QATAR HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 676 OMAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 677 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 678 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 679 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 680 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 681 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 682 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 683 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 684 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 685 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 686 OMAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 687 OMAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 688 OMAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 689 OMAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 690 OMAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 691 BAHRAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 692 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 693 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 694 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 695 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 696 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 697 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 698 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 699 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)
TABLE 700 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)
TABLE 701 BAHRAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 702 BAHRAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 703 BAHRAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 704 BAHRAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 705 BAHRAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 706 REST OF MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL HEART VALVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL HEART VALVE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL HEART VALVE DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL HEART VALVE DEVICES MARKET, AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 12 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD
FIGURE 13 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HEART VALVE DEVICES MARKET IN 2023 & 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR HEART VALVE DEVICES MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA
FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE
FIGURE 17 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC
FIGURE 18 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HEART VALVE DEVICES MARKET
FIGURE 20 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022
FIGURE 21 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 23 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2022
FIGURE 25 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)
FIGURE 27 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE
FIGURE 28 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2022
FIGURE 29 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)
FIGURE 30 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)
FIGURE 31 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 33 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 34 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 35 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 37 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022)
FIGURE 38 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2023 & 2030)
FIGURE 39 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022 & 2030)
FIGURE 40 GLOBAL HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 41 NORTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 42 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 43 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 44 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 45 NORTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 46 SOUTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 47 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 48 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 49 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 50 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 51 EUROPE HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 52 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 53 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 54 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 55 EUROPE HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 56 ASIA-PACIFIC HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 57 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 58 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 59 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 60 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY FUNCTIONALITY (2023-2030)
FIGURE 61 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 62 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 63 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 64 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 65 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 66 GLOBAL HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 EUROPE HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 ASIA-PACIFIC HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
